Pharmacological inhibition with the ataxia telangiectasia and Rad3-relevant protein serine/threonine kinase (ATR; often known as FRAP-associated protein (FRP1)) has emerged as a promising tactic for cancer remedy that exploits artificial lethal interactions with proteins involved in DNA problems repair, overcomes resistance to other therapies and improves antitumour immunity. Multiple... https://chamforth555vhs8.wikihearsay.com/user